Last reviewed · How we verify
multivitamin
At a glance
| Generic name | multivitamin |
|---|---|
| Also known as | Placebo Oxyvit C+, Placebo |
| Sponsor | New York State Institute for Basic Research |
| Drug class | Antidote [EPC] |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Boxed warnings
- Warnings: Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breast-feeding. Consult your doctor. Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient. Precautions Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folic acid to patients with undiagnosed anemia, since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered. For use on the order of a healthcare practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Common side effects
Key clinical trials
- Plant-Based Diet for Patients With Rheumatoid Arthritis (NA)
- Child Health, Agriculture and Integrated Nutrition (NA)
- Effect of Walnuts on Sperm Parameters and Male Fertility (NA)
- Multivitamin for Health and Cognition (NA)
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial (PHASE2, PHASE3)
- PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS) (NA)
- Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy (PHASE1)
- Effects of Melatonin on Excessive Crying in Neonates. A Randomized Controlled Clinical Trial. (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- multivitamin CI brief — competitive landscape report
- multivitamin updates RSS · CI watch RSS
- New York State Institute for Basic Research portfolio CI